Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances kratom regulation after heated testimony over potency caps and enforcement
Summary
Lawmakers advanced Senate Bill 72 to appropriations after contentious testimony from bereaved family members, public‑health advocates, small kratom businesses and industry groups over new labeling, registration and a 2% cap on 7‑hydroxymitragynine (7‑OH) in products.
The House Finance Committee voted to send Senate Bill 72 — a proposal to tighten state regulation of kratom products — to appropriations after lengthy and emotional testimony from supporters and opponents.
The bill would create a product registry and labeling standards, set a 2% cap on the alkaloid 7‑hydroxymitragynine (7‑OH) in products sold as kratom, ban adulterated or synthesized kratom alkaloids, require age restrictions and set testing and disclosure requirements. Sponsors said the changes respond to new, high‑potency products that have been linked to overdose deaths and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
